Jennifer R. Brown, MD, PhD, on ALPINE Data, CLL Highlights at ASH 2022
By Jennifer R. Brown, MD, PhD - Last Updated: December 20, 2022Blood Cancers Today caught up with the Society of Hematologic Oncology President Jennifer R. Brown, MD, PhD, to find out what she was watching at the 64th American Society of Hematology Annual Meeting. Dr. Brown highlighted data from the phase III ALPINE study, which compared zanubrutinib with ibrutinib as a treatment for patients with relapsed/refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.
Post Tags:ASH22
Advertisement
Related Posts
Novel therapies and “game-changing drugs” have made a major impact on the treatment of myeloma, Dr. Wong said.
Sandy Wong, MD, explains how clinicians and researchers can help educate others about myeloma.
Sagar Lonial, MD, FACP, Editor-in-Chief of Blood Cancers Today, discusses Multiple Myeloma Awareness Month.
Dr. Pickl discusses potential future uses and implications of a novel biomarker to predict responses to CAR-T in DLBCL.
Dr. Nabhan discusses his new book, "Toxic Exposure: The True Story behind the Monsanto Trials and the Search for Justice."
Advertisement
Advertisement
Editorial Board
Sagar Lonial, MD, FACPEditor-in-Chief | Chief Medical Officer of Winship Cancer Institute at Emory University School of Medicine
Elias Jabbour, MDAssociate Editor | Professor in the Department of Leukemia, Division of Cancer Medicine, MD Anderson Cancer Center
Thomas Martin, MDAssociate Editor | Clinical Research Director, UCSF Helen Diller Family Comprehensive Cancer Center
Jerald Radich, MDAssociate Editor | Professor in the Clinical Research Division and Kurt Enslein Endowed Chair at Fred Hutch
Laurie Sehn, MD, MPHAssociate Editor | Clinical Professor of Medical Oncology, British Columbia Cancer Centre for Lymphoid Cancer
Guillermo Garcia-Manero, MDAssociate Editor | Chief, Section of Myelodysplastic Syndromes, The University of Texas MD Anderson Cancer Center
Kami Maddocks, MDAssociate Editor | Professor of Clinical Internal Medicine in the Division of Hematology at The Ohio State University
670 Madison Ave.
Manalapan, NJ 07726